Q: Credo was rated Buy two weeks ago at $206.63. Why the downgrade at $150.09?

A: Because the trade failed on its own published terms. That report set a buy range of $185 to $200 and a cut-loss at $168. Credo opened on 2 September at $188.63, inside the range, and closed the same session at $165.22, below the stop. It has closed beneath $168 in every session since. Reaffirming a Buy here would ask readers to re-enter a position the coverage had already told them to exit.

Q: Did the company do something wrong?

A: No, and that is the awkward part. Fiscal first-quarter revenue of $479.0m grew 115% and beat both consensus and the guided range, the fifth straight quarter above the guided top end. Management lifted the full-year framing from more than 80% growth to more than 85% and reaffirmed the $600m-plus optical target. None of that has been revisited since. The moomoo news feed carries nothing company-specific between 5 September and a routine Form 144 filed on 14 September.

Q: So what took 27% out of the shares?

A: The discount rate and the sector. The 10-year Treasury yield reached 4.999% on 14 September, its highest since October 2023, after producer prices ran at 5.4% annually and core consumer prices beat forecast. Futures now price roughly 85% odds of a rate increase at the meeting concluding on 16 September. On Monday the VanEck Semiconductor ETF fell more than 4%, with Marvell down 7.6% and Coherent 12.7%. At a beta above three, Credo takes that move multiplied.

Q: Is the stock cheap now?

A: On the arithmetic, yes. At 24.3 times the $6.17 fiscal 2027 estimate derived from company guidance, against 33.5 times a fortnight ago, the probability-weighted fair value of $195 sits 30% above the market. But the previous report made the same cheapness argument at 33.5 times and the shares de-rated a further 27%. A multiple being set by the Treasury curve has no floor while that curve is still rising.

Q: What brings the rating back?

A: Two specific tests. A weekly close above $176, the 200-day average and the nearest structure overhead, with the Federal Reserve decision behind the market. Or the January quarter arriving near $687m when it is reported in late November, which would convert the second half from an assertion into a reported fact. The investment score is barely changed at 69.5 against 70, because better valuation offset worse risk and technicals.

The full risk register, scenario analysis and trade thresholds sit in the complete Credo Technology (CRDO) report on our Reports page.